To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 October 2018 to Question 183928 on Influenza: Vaccination, and with reference to the guidance, Flu Vaccination Programme Delivery Guidance 2018-19 published by NHS England, what assessment he has made of appropriateness of delivering aTIV to healthcare providers by mid-November.
The adjuvanted trivalent flu vaccine is the recommended vaccine for those aged 65 years and over because it is a more effective vaccine for this age group and should offer better protection against flu compared to those previously used in the United Kingdom programme. This is explained in the Flu Vaccination Programme Delivery Guidance 2018-19 available at the following link:
To ensure equitable access across the UK, deliveries of this vaccine are being phased between September and November. General practices and pharmacies were informed of the phased deliveries in April 2018 and given confirmed delivery dates in August. The supply to date has been on schedule.
With appropriate planning, all eligible patients should be able to be offered vaccine before the flu season starts.